Multi-omics integration uncovers epigenetic control of metabolic reprogramming in triple-negative breast cancer
Esraa M Hashem, Mai S Mabrouk · 2026
Read Multi-omics integration uncovers epigenetic control of metabolic reprogramming in triple-negative breast cancer by Esraa M Hashem, Mai S Mabrouk (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13538300.txt.
Description
Esraa Hashem and Mai Mabrouk join two data lenses on an aggressive breast cancer in a 2026 study. Triple negative breast cancer lacks the three receptors that guide most targeted drugs. Its growth leans on rewired metabolism, which gene silencing marks may drive. The team combined gene activity and methylation data to trace that interplay.
Key metabolic genes were dysregulated in the tumors: sugar burning and serine building enzymes rose, while metabolic tumor suppressors fell. Methylation maps showed matching shifts. Linking the two layers points to control points where the cancer's fuel lines could be cut. Data joining of this kind suits a cancer where single lens studies have stalled.
Catalog record
| CREATOR | Esraa M Hashem, Mai S Mabrouk |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 57 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |